Login / Signup

Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa.

Cristina NovembrinoIlaria QuagliaAngelo Claudio MolinariAlessandra BorchielliniAntonio CoppolaRita Carlotta SantoroMassimo Boscolo-AnzolettiEleonora GalbiatiEzio ZanonAlessandra Valpreda
Published in: Diagnostics (Basel, Switzerland) (2022)
Recombinant porcine factor VIII (rpFVIII) is indicated for treating bleeding episodes in acquired haemophilia A, but there are few data regarding laboratory methods to adequately monitor treatment. This study involving three Italian laboratories aimed to evaluate the analytical performance of different assays for measuring rpFVIII. Five spiked rpFVIII samples (0.5-1.5 IU/mL) were analysed on three days, in triplicate, with eleven combinations of reagents (Werfen, Boston, MA, USA: SynthasIL and SynthaFax for one-stage assay, Chromogenix Coamatic FVIII for chromogenic assay), FVIII depleted plasmas (with or without von Willebrand factor-VWF) and calibrators (HemosIL human calibrator plasma, porcine calibrator diluted in FVIII deficient plasma with or without VWF). The assays were performed on ACL TOP analysers (Werfen, Boston, MA, USA). Intra- and inter-assay and inter-laboratory Coefficient of Variation (CV%) were calculated together with percentage of recovery (% recovery) on the expected value. The results showed that the reagent combinations reaching satisfactory analytical performance are: SynthasIL/human calibrator/deficient plasma+VWF (total recovery 99.4%, inter-laboratory CV 4.04%), SynthasIL/porcine calibrator/deficient plasma+VWF (total recovery 111%, inter-laboratory CV 2.75%) and Chromogenic/ porcine calibrator/deficient plasma+VWF (total recovery 96.6%, inter-laboratory CV 8.32%). This study highlights that the use of porcine standard (when available) and FVIII deficient plasma with VWF should be recommended.
Keyphrases
  • high throughput
  • endothelial cells
  • liquid chromatography
  • atrial fibrillation
  • induced pluripotent stem cells
  • mass spectrometry
  • wild type
  • cell free
  • replacement therapy